N/A
N=65
Does Pulmonary Rehabilitation Improve Frailty?
Disease, Pulmonary
Bottom Line
View on ClinicalTrials.gov: NCT02512874 ↗Enrolled (actual)
65
Serious AEs
0.0%
Results posted
Oct 2018
Primary outcome: Primary: Number of Participants With Frailty Phenotype at Baseline and 6 Months — 24; 15 Participants — p=0.62
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Pulmonary Rehabilitation (Other); Dynamometer (Device); DEXA (Radiation); Gait Speed Test (Other); Activity Monitor (Device); Questionnaires (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Mayo Clinic
- Primary completion
- Oct 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Frailty Phenotype at Baseline and 6 Months |
24; 15 | 0.62 |
| SECONDARY Wasting |
0.04 | — |
| SECONDARY Change in Strength |
— | — |
| SECONDARY Change in Gait Speed |
-0.6 | — |
| SECONDARY Improvement in Exhaustion |
2 | — |
| SECONDARY Change in Physical Activity Level |
0.4 | — |
Summary
Frailty is a state of health with predisposition to adverse events, morbidity and mortality. Frailty consists of weakness, slowness, low physical activity, exhaustion, and wasting. Frailty is associated with increased hospitalizations and death in lung disease. It is unknown if pulmonary rehabilitation will improve frailty markers.
Eligibility Criteria
Inclusion criteria
- Referred for pulmonary rehabilitation
- consenting to research
Exclusion criteria
-Under 18 years of age
Data sourced from ClinicalTrials.gov (NCT02512874). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.